Corline Biomedical AB Sustainability Reports
Corline Biomedical AB develops and markets heparin-based surface coatings and treatments to improve tissue and organ transplant tolerance and medical device compatibility. The company supplies solutions to the regenerative medicine and medical device industries.
Sector: Professional & technical services
Country: Sweden
Exchange: Nasdaq Stockholm
LEI: 549300KYLOA3DVEPZ069
FIGI: BBG009BHZMY6
7 reports from 2015 to 2025
